Skip to main content
Premium Trial:

Request an Annual Quote

DNA Link Buys Orchid SNPStream System

NEW YORK, June 4 - DNA Link of Seoul, South Korea, has agreed to buy Orchid’s SNPstream 25K SNP-scoring system, the companies said.

"We acquired Orchid’s SNPstream 25K automated genotyping solution to enable us to accelerate our varied programs in medical genetics," Jong Eun Lee, co-CEO of DNA Link, said recently in a statement.

“We expect that the SNPstream system’s mix of accuracy, robustness, and cost effectiveness combined with access to Orchid’s growing SNP databases will contribute to the rapid progress of our gene discovery and pharmacogenetics programs,” he said.

DNA Link, a medical genetics research company, is Orchid’s first customer in Asia to buy the SNPstream system, which can analyze up to 25,000 SNPs per day.  

Financial terms of the agreement were not disclosed.

In addition to the SNPstream system, Orchid BioSciences of Princeton, NJ, also offers SNP scoring and pharmacogenetic testing services.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.